Cannabis Strategies Acquisition Corp. Announces Filing of Non-Offering Prospectus – Benzinga


TORONTO, Dec. 11, 2018 /CNW/ – Cannabis Strategies Acquisition Corp. (NEO: CSA.A, CSA.WT, CSA.RT) (“CSAC“) announces that, in accordance with applicable rules, it has filed a non-offering preliminary prospectus with the securities regulatory authorities in each of the provinces and territories of Canada, other than Quebec, in connection with the completion of its qualifying transaction.

On October 17, 2018, CSAC announced that it had entered into definitive agreements (the “Definitive Agreements“) to concurrently acquire the target businesses of Washoe Wellness, LLC (“Washoe“), The Canopy NV, LLC (“Canopy“), Sira Naturals, Inc. (“Sira“), LivFree Wellness LLC (“LivFree“) and CannaPunch of Nevada LLC, which are collectively intended to constitute CSAC’s qualifying transaction (the “Transaction“). The Transaction, upon closing, when final regulatory approvals are received from all applicable jurisdictions, is anticipated to create a combined enterprise with a strong combination of high-quality assets anchoring the Eastern and Western United States. Assuming closing of the Transaction, CSAC will own three cultivation and production facilities and eight dispensaries across the states of Nevada and Massachusetts, in addition to key licenses.

Pursuant to applicable rules, the prospectus contains disclosure of CSAC, to be renamed and continued into British Columbia, as the resulting issuer, assuming completion of the Transaction.

Following the issuance of a receipt for the final prospectus, CSAC will file and mail an information circular, to which the final prospectus will be attached, in connection with the special meeting of shareholders of CSAC (the “Meeting“) at which approval of the Transaction and related matters will be sought.

The Transaction remains subject to the satisfaction of certain conditions, including, among other things, United States state and local regulatory, Aequitas NEO Exchange Inc. and Canadian securities regulatory authority approvals, as well as certain third party consents and other closing conditions. There can be no assurance that these conditions

Read More Here...

Leave a Comment

Your email address will not be published. Required fields are marked *